Molecular and Functional Imaging/Surrogate Markers in Radiation Oncology

Nov. 26, 8:30-10:00 a.m. | S504AB

Learn about the potential of functional and molecular imaging before and after cytotoxic therapy in this session. It also covers the role of imaging as a predictor of tumor control and survival.

 

Speaker Information:

•             Nina A. Mayr, MD, Ohio State University, Columbus

•             Carryn Anderson, MD, University of Iowa, Iowa City

•             Jinxing Yu, MD, Virginia Commonwealth University, Richmond

•             William T. C. Yuh, MD, Ohio State University, Columbus

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.